Calcium Phosphate Cement in the Surgical Management of Benign Bone Tumors

Anticancer Res. 2018 May;38(5):3031-3035. doi: 10.21873/anticanres.12558.

Abstract

Background/aim: This study assessed the mid- to long-term outcomes of calcium phosphate cement (CPC) implantation in benign bone tumor surgery.

Patients and methods: Between 2000 and 2015, 130 patients underwent CPC implantation in benign bone tumor surgery. Radiographic findings and clinical outcomes were retrospectively evaluated.

Results: The mean follow-up period was 52 months. CPC filling immediately after surgery was sufficient, regardless of the amount of CPC used and the usage of adjuvant substances, which resulted in 92% of the patients' radiological results being classified as good or excellent. Significantly more patients had better CPC filling among patients with less hemorrhage and patients with tourniquet. The number of patients with good or excellent CPC filling had significantly increased by the final follow-up.

Conclusion: CPC is a useful bone substitute for benign bone tumor surgery providing excellent osteoconductivity and long-lasting stability without internal fixation.

Keywords: Calcium phosphate cement; benign bone tumor; complication; radiological outcomes.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bone Cements / therapeutic use*
  • Bone Neoplasms / surgery*
  • Bone Substitutes / therapeutic use*
  • Calcium Phosphates*
  • Child
  • Chondroitin Sulfates
  • Female
  • Humans
  • Hydroxyapatites
  • Male
  • Middle Aged
  • Orthopedic Procedures / methods*
  • Retrospective Studies
  • Succinates
  • Young Adult

Substances

  • Biopex
  • Bone Cements
  • Bone Substitutes
  • Calcium Phosphates
  • Hydroxyapatites
  • Succinates
  • Chondroitin Sulfates